PSD3 and hepatocellular carcinoma: In summary, PSD3 rs71519934 was associated with protection against FLD in individuals at risk and PSD3/Psd3 downregulation led to a reduction in hepatocellular fat content in human primary hepatocytes and in human and rodent hepatoma cells.